St. Jude Medical
Late Stage
What they invest in
from 2 of 2 portfolio companiesAI & Machine Learning ×1Biotech ×1Healthtech ×1Medical Devices ×1
HQs:United States×2
Investments · 2 tracked
founders shown can be your intro path
iRhythm provides wearable cardiac monitoring devices and AI-powered analysis services for clinicians to diagnose heart arrhythmias.
AI & Machine LearningHealthtechMedical DevicesSan Francisco, US
Kevin M. King(Executive Officer, Director)inShelly D. Guyer(Executive Officer)inWilliam F. Willis(Executive Officer, Director)Judith Lenane(Executive Officer)Steve Johnson(Executive Officer)in
BoardTiba Aynechi(Director)in
Co-investorsKaiser Permanente VenturesNorwest Venture PartnersNew Leaf Venture Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Exits · 1
IPOs and acquisitions across the tracked portfolioIrhythmtechNASDAQ: IRTC
IPO stake values · per SEC filings
Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.
| Company | Owned | IPO price | At IPO | Stake value |
|---|---|---|---|---|
| Irhythmtech | 5.1% | $17.00 | Oct 2016 | $18.2M |
Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).
Frequently asked questions
- What stage does St. Jude Medical invest at?
- St. Jude Medical invests at the Late Stage stage.
Media · Podcasts & interviews
from their channelUnderstanding the HeartMate 3 LVAD Heart Pump Therapy for Heart Failure Management
Abbott Cardiovascular
Obtención de lecturas con el dispositivo CardioMEMS HERO
Abbott Cardiovascular
HeartMate 3 LVAS Thoracotomy Implant Considerations Webinar
Abbott Cardiovascular
Grey’s Patient Story: Living with a HeartMate 3 LVAD for Heart Failure Management
Abbott Cardiovascular
Dennis’ Patient Story: Living with HeartMate 3 LVAD for Heart Failure
Abbott Cardiovascular
Cardiogenic Shock: The Impact of Early ECMO and Strong Partnerships
Abbott Cardiovascular
Images
Similar investors
3TS Capital Partners is a private equity and venture capital investor focused on technology and technology-enabled companies, notably in Central and Eastern Europe.
83North is a global venture capital firm that invests in and helps entrepreneurs build large, category-defining companies, backing startups across multiple stages and sectors.
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
Accel is a venture capital firm that partners with exceptional teams, positioning itself as a first partner to founders globally.